Mark Jones

21PUBLICATIONS

91CO-AUTHORS

Instrumental methods (excl. immunological and bioassay methods)Immunogenetics (incl. genetic immunology)Environmental biogeochemistryRespiratory diseasesNanomedicine

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|Jul 13, 2026

Beneficial effects of the AT<sub>2</sub> receptor agonist buloxibutid (C21) against acute alveolar epithelial cell inflammation during antiviral responses.

|May 05, 2026

Expanded detection of early fibrotic phenotypes using lobar traction bronchiolectasis in lung cancer screening.

|Sep 03, 2025

Air pollution and alveolar health.

Carmelo Sofia, James G H Parkin, Joseph A Bell

|Oct 01, 2024

1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.

Olivia C Leavy, Richard J Russell, Ewen M Harrison

|Jan 16, 2024

Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.

Giles Dixon, Samuel Hague, Sarah Mulholland

|Nov 16, 2023

Mortality surrogates in combined pulmonary fibrosis and emphysema.

An Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc

Pageof 4

Frequent Collaborators

7 joint publications

Joseph Jacob

6 joint publications

Christopher J Brereton

Donna E Davies

Yihua Wang

Matthew Loxham

Lareb S N Dean

Sam M Janes

Benjamin G Marshall

Iain Stewart

Franco Conforti

Frequent Collaborators

7 joint publications

Joseph Jacob

6 joint publications

Christopher J Brereton

5 joint publications

Donna E Davies

5 joint publications

Yihua Wang